Principal Scientist, CSL LimitedBiography
Dr Catherine Owczarek is the Director of the Recombinant Protein Expression Group (CSL Limited) located at the Bio21 Institute in Melbourne, Australia. After gaining a PhD at the John Curtin School of Medical Research, Canberra, Catherine completed her post-doctoral studies at the Sir William Dunn School of Pathology in Oxford, the Walter and Eliza Hall Institute in Melbourne and then was a Senior Research Fellow at the Monash Institute of Medical Research in Melbourne. Since joining CSL Limited in 2004 Catherine has led the CSL Research Group's efforts in the successful development of a program to produce mammalian-derived recombinant proteins using disposable cell culture technology. She is involved in a range of CSL's early phase drug discovery campaigns where there is a high demand for recombinant proteins.